Item 16. FORM 10-K SUMMARY

3K characters. Original on sec.gov · Markdown

Item 16. FORM 10-K SUMMARY

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	THE CLOROX COMPANY

Date: August 10, 2022	By:	/s/ Linda Rendle
		Linda Rendle
		Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


Signature	Title	Date
/s/ A. Banse	Director	August 10, 2022
A. Banse
/s/ R. H. Carmona	Director	August 10, 2022
R. H. Carmona
/s/ J. Denman	Director	August 10, 2022
J. Denman
/s/ S. C. Fleischer	Director	August 10, 2022
S. C. Fleischer
/s/ E. Lee	Director	August 10, 2022
E. Lee
/s/ A. D. D. Mackay	Director	August 10, 2022
A. D. D. Mackay
/s/ P. Parker	Director	August 10, 2022
P. Parker
/s/ S. Plaines	Director	August 10, 2022
S. Plaines
/s/ M. J. Shattock	Independent Chair	August 10, 2022
M. J. Shattock
/s/ K. Tesija	Director	August 10, 2022
K. Tesija
/s/ R. J. Weiner	Director	August 10, 2022
R. J. Weiner
/s/ C. J. Williams	Director	August 10, 2022
C. J. Williams
/s/ L. Rendle	Chief Executive Officer (Principal Executive Officer)	August 10, 2022
L. Rendle
/s/ K. B. Jacobsen	Executive Vice President – Chief Financial Officer (Principal Financial Officer)	August 10, 2022
K. B. Jacobsen
/s/ L. Peck	Vice President – Chief Accounting Officer and Corporate Controller (Principal Accounting Officer)	August 10, 2022
L. Peck

Previous: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES